Skip to main content

Published locations for Projected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare Analysis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Projected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare Analysis

User login

  • Reset your password
  • /content/projected-2023-cost-reduction-tumor-necrosis-factor-inhibitor-biosimilars-dermatology
  • /cutis/article/271278/psoriasis/projected-2023-cost-reduction-tumor-necrosis-factor-inhibitor
  • /dermatology/article/271278/psoriasis/projected-2023-cost-reduction-tumor-necrosis-factor-inhibitor